PlainRecalls
FDA Drug Moderate Class II Terminated

Compounded Plaquex, intravenous injection, 50 ML vial. Each ml contains: Phosphatidyl Choline 50 mg, Sodium Deoxycholate 25 mg, Benzyl Alcohol 0.9%, Ethanol (95%) 2.4 mg di Alpha Tocopheryl Acetate 0.2 mg in Sterile Water for injection.

Reported: February 18, 2015 Initiated: January 26, 2015 #D0384-2015

Product Description

Compounded Plaquex, intravenous injection, 50 ML vial. Each ml contains: Phosphatidyl Choline 50 mg, Sodium Deoxycholate 25 mg, Benzyl Alcohol 0.9%, Ethanol (95%) 2.4 mg di Alpha Tocopheryl Acetate 0.2 mg in Sterile Water for injection.

Reason for Recall

Good Manufacturing Practices Deviations: The product has an active pharmaceutical ingredient from an unapproved source.

Details

Recalling Firm
AnazaoHealth Corporation
Units Affected
51 vials
Distribution
Nationwide
Location
Las Vegas, NV

Frequently Asked Questions

What product was recalled?
Compounded Plaquex, intravenous injection, 50 ML vial. Each ml contains: Phosphatidyl Choline 50 mg, Sodium Deoxycholate 25 mg, Benzyl Alcohol 0.9%, Ethanol (95%) 2.4 mg di Alpha Tocopheryl Acetate 0.2 mg in Sterile Water for injection.. Recalled by AnazaoHealth Corporation. Units affected: 51 vials.
Why was this product recalled?
Good Manufacturing Practices Deviations: The product has an active pharmaceutical ingredient from an unapproved source.
Which agency issued this recall?
This recall was issued by the FDA Drug on February 18, 2015. Severity: Moderate. Recall number: D0384-2015.